CAS: 1035875-01-4
| Marca | Dados do produto | Pureza | Gama de preços | Estimativa de entrega |
|---|---|---|---|---|
 | 2-[(4,5-Dihydro-2-thiazolyl)thio]-1-(3,4-dihydroxyphenyl)-ethanone hydrobromide REF: 3D-KRB87501CAS: 1035875-01-4 | Min. 95% | A consultar | Seg 13 Jan 25 |
 | RETRA REF: TM-T24709CAS: 1035875-01-4 | 98% | 904,00 €~2.329,00 € | Ter 21 Jan 25 |
![2-[(4,5-Dihydro-2-thiazolyl)thio]-1-(3,4-dihydroxyphenyl)-ethanone hydrobromide](https://static.cymitquimica.com/products/3D/thumb/KRB87501.jpg)
2-[(4,5-Dihydro-2-thiazolyl)thio]-1-(3,4-dihydroxyphenyl)-ethanone hydrobromide
CAS:1035875-01-4
2-[(4,5-Dihydro-2-thiazolyl)thio]-1-(3,4-dihydroxyphenyl)-ethanone hydrobromide is a potent inhibitor of protein interactions and activator of ligands. It is …
Fórmula:
C11H12BrNO3S2
Pureza:
Min. 95%
Peso molecular:
350.3 g/mol
Ref: 3D-KRB87501
| 5mg | A consultar | ||
| 10mg | A consultar | ||
| 25mg | A consultar | ||
| 50mg | A consultar |
Entrega estimada em Estados Unidos, Segunda-feira 13 de Janeiro de 2025
RETRA
CAS:1035875-01-4
RETRA is an agent of anticancer that acts by exerting anticancer activity in Ewing's sarcoma …
Fórmula:
C11H12BrNO3S2
Pureza:
98%
Cor e Forma:
Solid
Peso molecular:
350.25
Ref: TM-T24709
| 25mg | 1.410,00 € | ||
| 50mg | 1.845,00 € | ||
| 100mg | 2.329,00 € |
Entrega estimada em Estados Unidos, Terça-feira 21 de Janeiro de 2025
